ACS Publications Unveils Multimodal Cell-Free Biosensing Platform for Highly Sensitive Detection of Lethal Mushroom Toxin α-Amanitin

July 5, 2026

ACS Publications USA

Overview

This research developed a transcription-based multimodal cell-free biosensing platform for highly sensitive detection of α-amanitin, a lethal mushroom toxin. The platform converts α-amanitin-dependent RNA polymerase inhibition into a measurable output via three independent signal transduction modules: fluorescence, colorimetric (gold nanoparticle aggregation), and RNAzyme-catalyzed enzymatic detection. It demonstrated high detection limits (LOD) of 1.30 μg/mL for fluorescence, 0.69 μg/mL for AuNP-based colorimetry, and 6.29 μg/mL for RNAzyme-based colorimetry, showing good selectivity and robust performance even in complex matrices. This technology significantly contributes to early food poisoning diagnosis and public health protection.

In Depth

Key Findings

Research published in ACS Publications describes the development of a transcription-based multimodal cell-free biosensing platform for the highly sensitive and versatile detection of α-amanitin, a lethal mushroom toxin. This innovative platform leverages the specific mechanism of α-amanitin inhibiting RNA polymerase, translating this inhibitory effect into measurable outputs via three independent signal transduction modules: fluorescence, colorimetric detection through gold nanoparticle aggregation, and enzymatic detection catalyzed by an RNAzyme. Notably, the AuNP-based colorimetric detection achieved a low limit of detection (LOD) of 0.69 μg/mL, demonstrating excellent selectivity and robust performance even in complex sample matrices. This represents a significant advancement in the rapid and reliable detection of toxic substances.

Technical / Clinical Details

The developed cell-free biosensing platform reconstructs the genetic transcription process in vitro. In the presence of α-amanitin, RNA polymerase activity is inhibited, leading to a reduction in the amount of the target RNA transcript. This change in RNA quantity manifests as distinct signals across the three detection modules. The fluorescence detection module utilizes a fluorescent probe that binds to RNA, detecting a decrease in RNA quantity as a drop in fluorescence intensity. In the gold nanoparticle (AuNP)-based colorimetric detection, specific RNA sequences control AuNP aggregation; thus, a reduction in RNA due to α-amanitin alters the AuNP aggregation state, resulting in a visually identifiable color change (e.g., red to blue). The RNAzyme-catalyzed enzymatic detection module relies on the catalytic activity of the RNAzyme, which is dependent on RNA quantity, so a decrease in RNA leads to a reduction in the colorimetric reaction intensity. While each module exhibits different LODs, their combined use enhances reliability and confirmability. This platform is particularly promising for applications requiring rapid and accurate results in toxicological emergencies and food safety testing.

Background & Context

α-Amanitin is an extremely potent toxin found in certain mushrooms, such as the Death Cap, and its ingestion typically leads to severe liver failure, often with fatal outcomes. Early diagnosis of mushroom poisoning is critical for enabling appropriate therapeutic interventions and significantly improving patient prognosis. However, existing methods for α-amanitin detection often require expensive equipment or lengthy analysis times. This cell-free biosensing platform overcomes these challenges by enabling rapid and low-cost detection directly at the point of need. The technology provides a new tool for food safety agencies and medical institutions to assess the risk of mushroom poisoning and protect public health.

Strategic Significance & Outlook

This multimodal cell-free biosensing platform possesses versatility, allowing its application beyond α-amanitin detection to other toxins, pathogens, or biomarkers. Future applications could include environmental monitoring of hazardous substances, rapid screening for allergens or contaminants in food, and even early diagnosis of infectious diseases in clinical settings. Further miniaturization and integration of this platform into portable devices could lead to the development of ‘lab-on-a-chip’ systems operable by users without specialized training. This will dramatically enhance on-site diagnostic capabilities across a wide range of fields, holding significant potential to contribute to a safer and healthier society.

Source: https://pubs.acs.org/doi/10.1021/acs.analchem.6c01287

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.